Key facts
- This page summarizes Dean J. Mitchell's Form 4 filing for PRECIGEN, INC. (PGEN).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2024, 18:14.
Dean J. Mitchell - 14 Mar 2024 Form 4 Insider Report for PRECIGEN, INC. (PGEN)
- Reporting relationship
- Director
- Issuer ticker
- PGEN
- Reported as of
- 14 Mar 2024
- Net transaction value
- +$56,499
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2024, 18:14:05 UTC
- Prior SEC filing
- 12 Mar 2024
- Next SEC filing
- 05 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dean J. Mitchell, by Donald P. Lehr, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dean J. Mitchell filed Form 4 for PRECIGEN, INC. (PGEN) on 18 Mar 2024.
Change
- Previous filing in this sequence was filed on 12 Mar 2024.
- Current net transaction value: +$56,499.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PGEN
transaction
Common Stock
Award
- Transaction value
- $56,499
- Shares
- +39,510
- Change %
- +8.5%
- Price
- $1.43
- Shares after
- 503,183
- Date
- 14 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PGEN
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +87,412
- Change %
- Price
- $0.000000
- Shares after
- 87,412
- Date
- 14 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 87,412
- Exercise price
- Footnotes
- F2, F3
PGEN
transaction
Derivative
Option to Purchase Common Stock (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +101,626
- Change %
- Price
- $0.000000
- Shares after
- 101,626
- Date
- 14 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 101,626
- Exercise price
- $1.43
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares were issued to the reporting person in lieu of an annual retainer of $56,499.
Footnote F2
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
Footnote F3
The RSUs vest in full on March 14, 2025.